Review of Tolvaptan’s Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions

Author： Bhatt Purav R.   McNeely Elizabeth B.   Lin Tess E.   Adams Kirkwood F.   Patterson J. Herbert  

Publisher： MDPI

E-ISSN： 2077-0383|3|4|1276-1290

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.3, Iss.4, 2014-11, pp. : 1276-1290

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluating Pharmacokinetic and Pharmacodynamic Interactions with Computational Models in Supporting Cumulative Risk Assessment

By Tan Yu-Mei   Clewell Harvey   Campbell Jerry   Andersen Melvin  

International Journal of Environmental Research and Public Health, Vol. 8, Iss. 5, 2011-05 ,pp. : 1613-1630

MDPI

Access to resources Recommend Favorite

Review of Pharmacokinetic, Pharmacodynamic and Clinical Studies with a Modern Combination of Amoxicillin/Sulbactam

By  

Chemotherapy, Vol. 52, Iss. 4, 2006-06 ,pp. : 200-204

Karger

Access to resources Recommend Favorite

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams

By Bolhuis Mathieu S.   Panday Prashant N.   Pranger Arianna D.   Kosterink Jos G. W.   Alffenaar Jan-Willem C.  

Pharmaceutics, Vol. 3, Iss. 4, 2011-11 ,pp. : 865-913

MDPI

Access to resources Recommend Favorite

Darunavir: A Critical Review of Its Properties, Use and Drug Interactions

By  

Pharmacology, Vol. 90, Iss. 1-2, 2012-07 ,pp. : 102-109

Karger

Access to resources Recommend Favorite

Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug–Drug Interactions

By Weiss Johanna   Gajek Thomas   Köhler Bruno Christian   Haefeli Walter Emil  

Pharmaceutics, Vol. 8, Iss. 1, 2016-02 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite